Chest-wall Surface Dose During Post-mastectomy Radiation Therapy, with and without Nonmagnetic Bolus: A Phantom Study

被引:2
|
作者
Choi, Cheon Woong [1 ]
Hong, Joo Wan [2 ,4 ]
Park, Cheol Soo [3 ]
Ahn, Jae Ouk [4 ]
机构
[1] Kyung Hee Univ Hosp Gangdong, Dept Resp & Crit Care Med, Seoul 05278, South Korea
[2] Seoul Natl Univ, Bundang Hosp, Dept Radiat Oncol, Songnam 13620, South Korea
[3] Hallym Polytech Univ, Dept Radiol Sci, Chunchon 24210, South Korea
[4] Soonchunhyang Univ, Dept Med IT Engn, Asan 31538, South Korea
关键词
nonmagnetic bolus; post-mastectomy; bolus; chest wall; surface dose; CLINICAL-PRACTICE GUIDELINES; SKIN DOSIMETRY; BREAST-CANCER; PHOTON BEAMS; RADIOTHERAPY; MOSFET;
D O I
10.4283/JMAG.2016.21.2.293
中图分类号
T [工业技术];
学科分类号
08 ;
摘要
For mastectomy patients, sufficient doses of radiation should be delivered to the surface of the chest wall to prevent recurrence. A bolus is used to increase the surface dose on the chest wall, whereby the surface dose is confirmed with the use of a virtual bolus during the computerized treatment-planning process. The purpose of this study is an examination of the difference between the dose of the computerized treatment plan and the dose that is measured on the bolus. Part of the left breast of an Anderson Rando phantom was removed, followed by the attainment of computed tomography (CT) images that were used as the basis for computerized treatment plans that were established with no bolus, a 3 mm-thick bolus, a 5 mm-thick bolus, and a 10 mm-thick bolus. For the computerized treatment plan, a prescribed dose regimen was dispensed daily and planning target volume (PTV) coverage was applied according to the RTOG 1304 guidelines. Using each of the established computerized treatment plans, chest-wall doses of 5 points were measured; this chest-wall dose was used as the standard for the analysis of this study, while the level of significance was set at P < 0.05. The measurement of the chest-wall dose with no bolus is 1.6 % to 10.3 % higher, and the differences of the minimum average and the maximum average of the five measurement points are -13.8 and -1.9, respectively (P < 0.05); however, when the bolus was used, the dosage was measured as 3.7 % to 9.2 % lower, and the differences of the minimum average and the maximum average are 7.4 and 9.0, -1.2 and 17.4, and 8.1 and 19.8 for 3 mm, 5 mm, and 10 mm, respectively (P < 0.05). As the thickness of the bolus is increased, the differences of the average surface dose are further increased. There are a variety of factors that affect the surface dose on the chest wall during post-mastectomy radiation therapy, for which verification is required; in particular, a consideration of the appropriate thickness and the number of uses when a bolus is used, and which has the greatest effect on the surface dose on the chest wall, is considered necessary.
引用
收藏
页码:293 / 297
页数:5
相关论文
共 35 条
  • [1] Clinical Advantage of Chest-wall Post-mastectomy Radiation Therapy Without Bolus
    Shiba, Shintaro
    Okamoto, Masahiko
    Kiyohara, Hiroki
    Okan, Naoko
    Yoshimoto, Yuya
    Murata, Hiroto
    Irie, Daisuke
    Katoh, Hiroyuki
    Nakano, Takashi
    IN VIVO, 2018, 32 (04): : 961 - 965
  • [2] Post-mastectomy radiation therapy without usage of a bolus may be a reasonable option
    Nakamura, Naoki
    Arahira, Satoko
    Zenda, Sadamoto
    Yoneyama, Kimiyasu
    Mukai, Hirofumi
    Onozawa, Masakatsu
    Toshima, Masamichi
    Motegi, Atsushi
    Hirano, Yasuhiro
    Hojo, Hidehiro
    Kibe, Yuichi
    Akimoto, Tetsuo
    JOURNAL OF RADIATION RESEARCH, 2017, 58 (01) : 66 - 70
  • [3] Outcomes in Patients Treated with Post-mastectomy Chest Wall Radiotherapy without the Routine Use of Bolus
    Yap, M. L.
    Tieu, M.
    Sappiatzer, J.
    Panzarella, T.
    Cuartero, J.
    McCready, D.
    Fyles, A.
    CLINICAL ONCOLOGY, 2018, 30 (07) : 427 - 432
  • [4] Dosimetric comparison of TomoDirect and TomoHelical plans in post-mastectomy chest wall radiation therapy
    Teke, F.
    Dogan, M. H.
    Kaya, M. A.
    Gumus, M.
    INTERNATIONAL JOURNAL OF RADIATION RESEARCH, 2017, 15 (03): : 259 - 266
  • [5] Post-mastectomy radiation beyond chest wall in patients with N1 breast cancer: Is there a benefit?
    Yadav, Budhi Singh
    Sharma, S. C.
    George, Philip
    Bansal, Anushama
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2014, 10 (02) : 279 - 283
  • [6] Suggestion for the omission of post-mastectomy chest wall radiation therapy in patients who underwent skin-sparing/nipple-sparing mastectomy
    Kim, Nalee
    Park, Won
    Cho, Won Kyung
    Kim, Hae Young
    Choi, Doo Ho
    Nam, Seok Jin
    Kim, Seok Won
    Lee, Jeong Eon
    Yu, Jonghan
    Chae, Byung Joo
    Lee, Se Kyung
    Ryu, Jai Min
    Mun, Goo-Hyun
    Pyon, Jai-Kyong
    Jeon, Byung-Joon
    BREAST, 2022, 66 : 54 - 61
  • [7] Outcome of treatment for breast cancer patients with chest wall recurrence according to initial stage: Implications for post-mastectomy radiation therapy
    Chagpar, A
    Kuerer, HM
    Hunt, KK
    Strom, EA
    Buchholz, TA
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 57 (01): : 128 - 135
  • [8] A dosimetry study of post-mastectomy radiation therapy with AeroForm tissue expander
    Lim, Seng Boh
    Kuo, Li Cheng
    Li, Guang
    Kuo, Hsiang-Chi
    McCormick, Beryl
    Cahlon, Oren
    Powell, Simon
    Hong, Linda X.
    JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 2020, 21 (09): : 33 - 38
  • [9] Using the Bolus in Post-mastectomy Radiation Therapy (PMRT): A National Survey on Behalf of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) Breast Cancer Group
    Nuzzo, Marianna
    Ursini, Lucia Anna
    Patani, Fabiola
    Rosa, Consuelo
    Trignani, Marianna
    Di Tommaso, Monica
    Meattini, Icro
    Gregucci, Fabiana
    Ciabattoni, Antonella
    Genovesi, Domenico
    Caravatta, Luciana
    ANTICANCER RESEARCH, 2020, 40 (11) : 6505 - 6511
  • [10] Helical tomotherapy for post-mastectomy radiation therapy with or without breast implant: a single institution experience
    Dejean, Romain
    Chaltiel, Leonor
    Izar, Francoise
    Chira, Ciprian
    Leray, Helene
    Jouve, Eva
    Simon, Luc
    Massabeau, Carole
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2022, 35 : 37 - 43